MedPath

Effect of TEAS on the Incidence Rate of SIRS in Patients Undergoing Abdominal Surgery

Not Applicable
Completed
Conditions
Inflammation
Systemic Inflammatory Response Syndrome
Interventions
Device: TEAS
Device: Sham TEAS
Registration Number
NCT02193477
Lead Sponsor
Air Force Military Medical University, China
Brief Summary

The purpose of this study is to access the effect of Transcutaneous Electrical Acupoint Stimulation(TEAS) on the Incidence rate of Systemic Inflammatory Response Syndrome (SIRS) in patients undergoing radical surgery for gastric cancer

Detailed Description

Patients undergoing elective radical surgery for gastric cancer under general anesthesia were randomly assigned to three groups, control group , TEAS group and sham TEAS group.

TEAS group receiving TEAS before general anesthesia induction , 1th day and 2nd day after surgery. TEAS was given through electrodes attached to specific acupoints. The time for TEAS was 30min.

Sham TEAS group receiving sham TEAS before general anesthesia induction , 1th day and 2nd day after surgery. Sham TEAS was given through electrodes attached to non-acupoints. The time for sham TEAS was also 30min.

Control group were given no TEAS. Incidence rates of SIRS in each group were compared .Venous blood samples from all groups(control group , TEAS group and sham TEAS group) were collected before general anesthesia induction,1th day and 3rd day after surgery. Inflammatory cytokines index including interleukin-6,interleukin-10,Tumor Necrosis Factor- alpha(TNF-α),Interferon-γ(IFN-γ),Monocyte Chemotactic Protein 1(MCP-1),IgG,IgM were measured.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
105
Inclusion Criteria
  • Age>30yrs,<75yrs
  • ASA 1-2
  • Scheduled for radical surgery for gastric cancer under general anesthesia;
  • Informed consented
Exclusion Criteria
  • Patients with implanted pacemakers
  • Patients with severe hypertension or cardiac dysfunction;
  • Patients with severe pulmonary disease
  • Patients with hemoglobin<90g/L

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
TEAS TreatmentTEASPatients were given 30min of TEAS before general anesthesia induction, 1th day and 2nd day after surgery.
Sham TEASSham TEASPatients were given 30min of sham TEAS before general anesthesia induction,1th day and 2nd day after surgery.
Primary Outcome Measures
NameTimeMethod
Incidence rate of SIRS1st day after surgery

SIRS is defined as 2 or more of the following variables :

1. Fever of more than 38°C (100.4°F) or less than 36°C (96.8°F)

2. Heart rate of more than 90 beats per minute

3. Respiratory rate of more than 20 breaths per minute or arterial carbon dioxide tension (PaCO2) of less than 32mm Hg

4. Abnormal white blood cell count (\>12,000/µL or \< 4,000/µL or \>10% immature granulocyte forms)

Incidence rate of SIRS is calculated using the following formula:

(Number of SIRS Cases within the group) / (Number of Cases within the group)

Secondary Outcome Measures
NameTimeMethod
Change of Inflammatory cytokines30 minutes before general anesthesia induction and 1st and 3rd day after the surgery

Venous blood samples were collected before general anesthesia induction,1th day and 3rd day after surgery. Inflammatory cytokines index including interleukin-6,interleukin-10,TNF-α,Interferon-γ(IFN-γ),Monocyte Chemotactic Protein 1(MCP-1),IgG,IgM were measured.

Incidence rate of SIRS3rd day after surgery

SIRS is defined as 2 or more of the following variables :

Fever of more than 38°C (100.4°F) or less than 36°C (96.8°F) Heart rate of more than 90 beats per minute Respiratory rate of more than 20 breaths per minute or arterial carbon dioxide tension (PaCO2) of less than 32mm Hg Abnormal white blood cell count (\>12,000/µL or \< 4,000/µL or \>10% immature granulocyte forms)

Incidence rate of SIRS is calculated using the following formula:

(Number of SIRS Cases within the group) / (Number of Cases within the group)

Trial Locations

Locations (1)

Fourth Military Medical University

🇨🇳

Xi'an, Shanxi, China

© Copyright 2025. All Rights Reserved by MedPath